Who are T1International?
T1International is a global type 1 diabetes advocacy organisation led by people with type 1 diabetes for people with type 1 diabetes. T1International believes in a world where everyone with type 1 diabetes – no matter where they live – has everything they need to survive and achieve their dreams. The organisation accepts no funding from pharmaceutical companies and provides advocacy training and support to advocates. In 2014, T1International launched the #insulin4all campaign, which has grown into a global movement. T1International supports advocates and partners in more than 20 countries around the world. For more information, and to support the cause, visit www.t1international.com.
Support T1International by Purchasing a FRIO Wallet
20% of your purchase helps T1International to achieve its goal of a world where everyone with type 1 diabetes – no matter where they live – has everything they need to survive and achieve their dreams.
FRÍO® keeps temperature sensitive medicines within safe temperatures of 18-26°C (64.4-78.8°F) for a minimum of 45 hours, even in a constant environmental temperature of 37.8°C (100°F).
FRIO the world’s first patented cooling wallet
– Simply activate with cold water!
– Light and compact
– Reusable
With a minimum continuous cool period of 45 hours and a recharge time of under 5 minutes, FRIO is made for your everyday – wherever that might be!
Why is T1International’s service so vital?
According to the WHO, an estimated 422 million adults were living with diabetes around the world as of 2014. The same report notes that separate global estimates of diabetes prevalence for type 1 and type 2 do not exist. This lack of data around type 1 diabetes in and of itself is a big problem. Some approximations say that more than 40 million people around the world live with type 1 diabetes. A large proportion of people with diabetes live in places with inadequate healthcare, which means there are likely hundreds of thousands of people (or more) facing death due to lack of insulin.